Nicholas Hoffman & Company, Llc. Haleon PLC Transaction History

Nicholas Hoffman & Company, Llc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 06, 2023	SELL	$7.85 - $8.94 $1,789 - $2,038	-228 Reduced 0.52%	43,891 $365,000
Q2 2023 Aug 09, 2023	SELL	$8.04 - $9.0 $4,823 - $5,400	-600 Reduced 1.34%	44,119 $369,000
Q1 2023 May 15, 2023	SELL	$7.57 - $8.37 $1,249 - $1,381	-165 Reduced 0.37%	44,719 $364,000
Q4 2022 Feb 13, 2023	SELL	$5.96 - $8.06 $26,790 - $36,229	-4,495 Reduced 9.1%	44,884 $359,000
Q3 2022 Nov 04, 2022	BUY	$5.63 - $7.5 $278,003 - $370,342	49,379 New	49,379 $301,000

639

412M

149K

16K

Ticker HLN
Exchange
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 4,617,290,240
Market Cap $44.8B
Description
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...

Get notified when there are updates to the investment portfolio of Nicholas Hoffman & Company, Llc., based on Form 13F filings with the SEC.

Stay updated on Nicholas Hoffman & Company, Llc. with notifications on news.